INTRODUCTION
Breast cancer is the most commonly diagnosed form of cancer among women in the United States (with the exception of nonmelanoma skin cancer) and is a significant cause of morbidity and mortality. Breast cancer is estimated to account for 30% of newly diagnosed cancers among women in 2017. 1 Elderly women are of special interest because they experience the highest incidence of breast cancer by age. 2 Although the rate of breast cancer deaths has been declining since the late 1980s, . 40,000 women are expected to die as a result of breast cancer in 2017 alone. 1 Compared with the general population, patients with mental illness face a much higher overall rate of mortality, with a recent study having estimated a life expectancy reduction of up to 24 years in those with severe mental disorders. [3] [4] [5] [6] [7] [8] Moreover, this inequality in mortality has been increasing over the past few decades. 9 Chronic conditions such as cardiovascular disease and cancer account for the majority of deaths in people with mental illness.
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Although the incidence of breast cancer has been shown to be slightly lower in women with mental illness compared with those without, the mortality rate has been shown to be higher. Nearly all known studies have shown a positive association between aggregate measures of mental illness and both all-cause and breast cancer-specific mortality. [11] [12] [13] [14] [15] [16] [17] Many factors could explain these associations, with screening, access to care, diagnosis, and treatment delays often cited as key considerations.
Although the literature seems to support a positive association between mental illness and mortality among patients with breast cancer, only one known study used a competing risk analysis to study the effects on breast cancer-specific mortality, and few studies have examined the effect of specific preexisting mental health conditions on survival outcomes. 6, 7, 12, 18, 19 We addressed these limitations by examining the effect of severe mental illness on all-cause and breast cancer-specific mortality among elderly patients with breast cancer in the United States.
METHODS

Setting
A retrospective cohort study was conducted by using linked SEERMedicare data files. The SEER registries capture incident cancer cases for approximately 28% of the United States and are an established populationbased source for cancer information. 20 Medicare is a US federal health insurance program that provides coverage for most adults $ 65 years of age. Approximately 97% of older adults in the United States are enrolled in Medicare Part A, which provides coverage for hospitalizations, and 96% of older adults with Part A pay a premium to enroll in Part B, which covers physician and other outpatient services. Approximately 93% of older patients in SEER have been linked with Medicare enrollment records, which demonstrates the completeness of these records. 21 
Study Population
Women $ 68 years of age diagnosed with stage I, II, or IIIa incident  breast cancer between 2005 and 2007 were identified in the SEER-Medicare linked data files. Patients were required to have continuous enrollment in Medicare Parts A and B with fee-for-service coverage for 3 years before breast cancer diagnosis. Patients were excluded from the study if the source of the breast cancer diagnosis was noted as death certificate or autopsy, if another cancer was noted in addition to breast cancer, or if a diagnosis of dementia or personality disorder was recorded on any claim during the 3 years before breast cancer diagnosis. Patients with dementia and personality disorder were excluded because these disorders are distinct and different from the other types of mental illnesses considered in this analysis. Patients also were excluded if the month of breast cancer diagnosis was missing from the SEER record. Figure 1 shows additional information about the study population, including the number of patients who were excluded for each reason.
Outcomes
Patients were followed from the date of breast cancer diagnosis until the end of December 2010. Survival time was obtained from the SEER record. Information on cause of death also was obtained from the SEER record and was used to determine whether each patient died as a result of breast cancer or another cause or was alive at the end of the follow-up period. The primary outcomes of interest for the study were time to allcause death and time to breast cancer-specific death.
Mental Illness
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes were used to determine the presence of severe mental illness, including bipolar disorder, schizophrenia, and other psychotic disorders (295, 297, 298, 293.81, 293.82, 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 296.9). Although the primary focus of this study was severe mental illness, we also identified patients with anxiety (308, 293.84, 300.0, 300.1, 300.2, 300.89) and depression (296.2, 296.3, 300. 4 (n = 28) (n = 820) (n = 49) (n = 3,795) (n = 496) (n = 1,151) (n = 1,465) (n = 683) a patient had anxiety and/or depression along with severe mental illness, she was classified as having severe mental illness. A patient was considered to have a given condition if a relevant code was present on at least one inpatient or at least two outpatient claims during the 3-year monitoring period.
Other Variables
Demographic variables were obtained from the SEER record, including age at the time of breast cancer diagnosis, census tract median income, race, ethnicity, SEER registry location, and marital status. Tumor characteristics also were obtained from the SEER record, including American Joint Committee on Cancer stage at diagnosis, estrogen receptor status, progesterone receptor status, histologic grade, tumor size, and number of positive lymph nodes. Medicare claims from the 3 years before breast cancer diagnosis were used to identify documented tobacco use and the number of comorbid conditions on the basis of ICD-9-CM codes.
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Statistical Analysis
For descriptive purposes, the distribution of patients with breast cancer and severe mental illness or without mental illness by demographic characteristics, comorbidities, documented tobacco use, and tumor characteristics was obtained. For all-cause mortality, the cumulative incidence was determined by using Kaplan-Meier and compared for patients with severe mental illness and without mental illness by using the log-rank test. For breast cancer-specific mortality, the cumulative incidence of breast cancer-specific death was determined and compared for these groups by using Gray's method. 23 Cox proportional hazards regression was performed to determine associations between mental illness and all-cause mortality. Regression on cumulative incidence functions was performed by using Fine and Gray's method to assess associations between mental illness and breast cancer-specific death after accounting for competing risks. 24 All regression analyses evaluated the effects of severe mental illness relative to no mental illness after adjusting for age, income, race, ethnicity, SEER registry location, and marital status. We also determined the effects of anxiety, depression, and co-occurring anxiety and depression. Patients who were alive at the end of the follow-up period were censored. All statistical analyses were conducted with SAS software, version 9.2 (SAS Institute, Cary, NC).
RESULTS
A total of 19,028 patients with breast cancer were included in the study. Of these patients, 2.6% had a diagnosis of preexisting severe mental illness, 80.1% had no preexisting mental health diagnosis, 7.7% had depression, 6.0% had anxiety, and 3.6% had both anxiety and depression. Table 1 lists the distribution of patients with severe mental illness and without mental illness by demographic characteristics, comorbidities, and documented tobacco use. A higher percentage of patients with severe mental illness had documented tobacco use and three or more comorbid conditions than those without mental illness. The census tract median income level was lower for those with severe mental illness, and a smaller percentage were married. Tumor characteristics at the time of breast cancer diagnosis are listed in Table 2 . Compared with patients without mental illness, a larger proportion of patients with severe mental illness was diagnosed beyond stage I, had at least one positive lymph node, had a tumor size . 20 mm, and had poorly differentiated tumors.
The unadjusted cumulative incidence curves for all-cause mortality are shown in Figure 2 . The cumulative incidence for all-cause mortality in patients with severe mental illness was 38.0% (95% CI, 31.4% to 44.5%) compared with 19.4% (95% CI, 17.8% to 20.3%) in patients without mental illness (P , .001). The unadjusted cumulative incidence curves for breast cancer-specific mortality are shown in Figure 3 . The cumulative incidence of breast cancer-specific death was 7.2% (95% CI, 4.6% to 10.6%) in patients with severe mental illness versus 6.2% (95% CI, 5.6% to 6.7%) in patients without mental illness (P = .1223).
Results from the regression analyses are listed in Table 3 . For each category of mental illness except anxiety, a significant positive association was observed with all-cause death after adjusting for ‡Value has been suppressed in accordance with SEER-Medicare data suppression guidelines.
jco.org age, income, race, ethnicity, SEER registry location, and marital status. However, the strongest effect was seen in those with severe mental illness. We also observed a nonstatistically significant increased hazard for breast cancer-specific death among patients with severe mental illness relative to patients without mental illness after accounting for competing risks.
DISCUSSION
In the current study, elderly patients with breast cancer and mental illness faced an increased all-cause mortality hazard. This relationship was especially pronounced for those with severe mental illness, who faced a twofold increased hazard for all-cause mortality compared with those without mental illness. Patients with severe mental illness also demonstrated a 20% increased hazard for breast cancer-specific death, but the hazard ratio was not significant. Our descriptive analysis shows that patients with severe mental illness were diagnosed with later-stage breast cancer more frequently compared with patients without mental illness, which suggests that delayed diagnosis might play a role in survival disparities.
Earlier studies have shown that overall survival is decreased in patients with breast cancer and mental illness, 11, 12, [14] [15] [16] and the negative effect of mental illness on mortality is not limited to patients with breast cancer. [3] [4] [5] [6] [7] [8] Chesney et al 8 performed a systematic literature review that assessed all-cause mortality in patients with mental illness. All forms of mental illness demonstrated an increased risk of all-cause mortality compared with no mental illness. Specifically, patients with severe mental disorders had increased risks that ranged from 120% to 150% higher, whereas those with depression only or with comorbid anxiety and depression had increased risks of 60% and 40% higher, respectively. These findings are consistent with those of the current study where severe mental illness carried the largest increase, 119%, followed by depression alone, comorbid anxiety and depression, and then anxiety alone.
Previous research that addressed the effect of preexisting mental illness on breast cancer-specific survival has been limited. In a population-based study of New Zealand women younger than 65 years, Cunningham et al 12 found an increased breast cancerspecific mortality hazard for patients with severe mental illness (schizophrenia, schizoaffective disorder, bipolar affective disorder, other nonorganic psychosis) after accounting for competing risks. Although not statistically significant, the current findings of an elevated hazard for breast cancer-specific death and more aggressive tumor characteristics among patients with severe mental illness are consistent with this previously published study. Cunningham et al also reported an increased hazard for women who were in contact with mental health services for other reasons, but they were unable to study the effects of specific mental health diagnoses other than those that were severe.
The presence of mental illness can affect rates of survival through many pathways. Comorbidity and tobacco use likely explain some of our findings. In the current study, 41.7% of patients with severe mental illness had $ 3 medical comorbidities compared with just 19.3% of those without mental illness, and the literature has consistently reported a shorter survival in patients with breast cancer with comorbid mental illness relative to those without. 25 Tobacco use is a behavioral risk factor that is present to Cumulative incidence for all-cause death in patients with breast cancer with severe mental illness and without mental illness. Results from the log-rank test suggest a significant difference between these patient groups (P , .001). a much higher degree in patients with mental illness. Although tobacco use was likely underestimated in this study because of a low sensitivity of existing ICD-9-CM codes, the difference in documented use between patients with severe mental illness and patients without mental illness was large (9.5% v 3.7%). Research has shown that cigarette smoking increases the risk of death from any cause, and in patients with cancer, smoking also increases the risk of dying as a result of cancer.
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Patients with mental illness often face a phenomenon known as diagnostic overshadowing where a patient's physical symptoms are mistakenly viewed as manifestations of their mental illness. Diagnostic overshadowing poses a barrier for patients with mental illness who often believe that they encounter discrimination from medical staff. 27 In addition, patients with severe mental illness could experience psychoses and/or cognitive dysfunction, in which case, they might not be able to understand the importance of obtaining mammograms, their symptoms, their diagnosis, or why they would need to initiate or continue treatment. A recently published study documented initial treatment delays among elderly patients with breast cancer and severe mental illness. 28 In an effort to address these issues, primary care physicians should counsel patients to adhere to the recommended breast cancer screening guidelines. They should also work with psychiatrists and oncologists on care coordination to improve early detection and breast cancer outcomes among patients with severe mental illness.
Oncologists should ensure that patients with breast cancer receive surveillance mammograms as part of their follow-up care.
Medications prescribed for mental illness also may play a role in the outcomes that we observed. For example, antipsychotics often are used to treat severe mental illnesses, such as schizophrenia or bipolar disorder. Hyperprolactinemia is a common adverse effect of treatment with typical antipsychotic agents and the atypical antipsychotic agent risperidone. Hyperprolactinemia has been associated with an increased risk of breast cancer in postmenopausal women. In addition, administration of prolactin in mice has been shown to increase the rate of mammary tumors. 29 Lithium chloride is another medication approved for the treatment of bipolar disorder. Suganthi and colleagues 30, 31 demonstrated that lithium can promote mammary tumors at low doses. Although the effect on human breast tumors is yet to be fully elucidated, the potential exists for these medications to contribute to a poorer prognosis in the patients with breast cancer who take them.
Several limitations should be considered in the context of this analysis. The use of psychiatric medications and the role of behavioral factors, such as alcohol use, substance abuse, and inadequate physical activity, could not be assessed. This study included patients $ 68 years of age with Medicare coverage who were not enrolled in a managed care plan. Therefore, the results might not be generalizable to patients outside this population. For example, the effects of severe mental illness on mortality could be even stronger among women younger than 68 years. The length of follow-up time also was relatively short, and the findings might have varied had we observed patients for a longer period. In addition, records were not available for services that patients paid for out-of-pocket, and reports of mental illness were based on ICD-9-CM codes reported on claims, which could lead to underreporting with respect to mental illness. For example, Medicare coverage for mental health benefits is limited, so some patients with mental illness may not have sought care during the 3 years before their breast cancer diagnosis. Of note, a gold standard does not exist for the identification of mental illness through claims data; conclusive information is not available in the literature about how to best identify patients with specific conditions. 32 The separation of patients with anxiety, depression, and comorbid anxiety/depression may be particularly problematic. [33] [34] [35] [36] Like other studies that have used administrative data, ours was subject to misclassification with respect to mental illness. For comparability with other studies of large administrative databases, we chose to use a conservative approach to the identification of mental illness (relevant code present on at least one inpatient or at least two outpatient claims); however, we did reevaluate study findings after assuming a less-conservative algorithm, an approach recommended by Frayne et al. 32 Use of this algorithm (relevant code on least one inpatient or one outpatient claim) resulted in a significant positive association between severe mental illness and breast cancer-specific mortality (adjusted hazard ratio 1.40; 95% CI, 1.02 to 1.92; Appendix Table A1 , online only). Cumulative incidence for breast cancer-specific death in patients with breast cancer with severe mental illness and without mental illness. The y-axis has been scaled to range from 0 to 0.06. Results from Gray's test do not show a significant difference between these patient groups (P = .1223). This study also has several other strengths. Most notably, the study included a large cohort that was representative of most elderly women with breast cancer in the United States. In addition, we used an analytic approach that accounted for the presence of competing risks.
In conclusion, elderly patients with breast cancer with preexisting mental illness experience increased all-cause mortality. This effect is strongest for those with severe mental illness who may also experience an increased risk of being diagnosed with advanced breast cancer and more aggressive tumor characteristics. These patients also have increased tobacco use and more comorbidities. Primary care physicians must place an emphasis on early detection among women with severe mental illness to improve the likelihood that guideline-recommended screening mammograms occur. They also should work closely with psychiatrists and oncologists on the coordination of care for these patients. Oncologists should ensure that patients with breast cancer receive surveillance mammograms as part of their follow-up care. More research is needed to determine models of coordination that work best to improve outcomes among patients with severe mental illness and to further elucidate the causal pathways between mental illness and reduced survival among patients with breast cancer. An understanding of how factors such as care use and quality and treatment decisions influence outcomes in this vulnerable population can help to inform changes in clinical practice.
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